Day

November 8, 2017

Casado LF, Hernández JA, Jarque I, Echave M, Casado MA, Castro A

 

 

Cost-utility of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia
20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

POSTER

Sabater E, Puente J, Oyagüez I, García-Campelo R, Reguart N, Rodriguez D, Cobo M, Moran M, Soto J

 

 

Cost-effectiveness of sequential treatment containing crizotinib for non small cell lung cancer (ALK+) patients
20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

POSTER

Mareque M, Oyagüez I, Morano R, Casado MA

 

 

 

Systematic review of herpes zoster epidemiology: available evidence in Spain related to specific sub-populations
20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

POSTER

Peral C, Gomez I, Burgos R , Rebollo F

 

 

 

Economic evaluations of etanercept in patients with psoriasis and psoriatic arthritis in Spain: a systematic review
20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

POSTER

Martínez-Sesmero JM, Burgos R, Jornet S, Santiago A, Navarro H, Gorgas Q, Jolonch P, Díaz Moreno V, Griffa L, Oyagüez I

 

 

Economic evaluation of a patient support programme Abbvie Care 2.0 Immunologyain
20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

POSTER